phenylephrine has been researched along with Diabetic Angiopathies in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (31.25) | 18.2507 |
2000's | 8 (50.00) | 29.6817 |
2010's | 3 (18.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ait-Aissa, K; Ali, M; Kassan, M; Matrougui, K; Trebak, M | 1 |
Kobayashi, T; Matsumoto, T; Taguchi, K; Watanabe, S | 1 |
Gurney, AM; Howarth, FC | 1 |
Bratz, IN; Damron, DS; Guarini, G; Haney, RM; Meszaros, JG; Ohanyan, VA; Raman, P; Talasila, PK; Thodeti, CK | 1 |
Brancaleone, V; Bucci, M; Cicala, C; Cirino, G; Di Lorenzo, A; Farneti, S; Fiorucci, S; Lin, MI; Pinto, A; Roviezzo, F; Sessa, WC | 1 |
Anderson, TJ; Berger, JP; Howarth, AG; Jiang, Y; Pannirselvam, M; Severson, D; Triggle, CR; Wiehler, WB | 1 |
Abraham, NG; Ahmad, M; Gupte, SA; Mingone, CJ; Turkseven, S; Wolin, MS | 1 |
Goseki, T; Ishikawa, H; Mashimo, K; Nishimoto, H; Shimizu, K; Uga, S; Yoshitomi, T | 1 |
Drábiková, K; Jancinová, V; Nosál', R; Nosál'ová, V; Okruhlicová, L; Sotníková, R; Zúrová-Nedelcevová, J | 1 |
Bernátová, I; Drábiková, K; Jancinová, V; Kristová, V; Navarová, J; Nosál'ová, V; Petríková, M; Snirc, V; Sotníková, R; Zúrová-Nedelcevová, J | 1 |
Belmadani, S; Boulares, HA; Gonzalez-Villalobos, RA; Matrougui, K; Palen, DI | 1 |
Benbow, S; Bodmer, CW; Masson, EA; Patrick, AW; Savage, MW; Williams, G | 1 |
Beckmann, R; Goessl, C; Knispel, HH | 1 |
Creager, MA; Creager, SJ; Cusco, JA; Johnstone, MT; Lee, BK; Scales, KM | 1 |
Amado, J; Berrazueta, J; Fleitas, M; Ochoteco, A; Poveda, J; Salas, E | 1 |
Kárpáti, E; Szombathelyi, Z; Till, A | 1 |
16 other study(ies) available for phenylephrine and Diabetic Angiopathies
Article | Year |
---|---|
Augmented EGF receptor tyrosine kinase activity impairs vascular function by NADPH oxidase-dependent mechanism in type 2 diabetic mouse.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cytochrome b Group; Diabetes Mellitus, Type 2; Diabetic Angiopathies; ErbB Receptors; Mice; Mice, Knockout; NADPH Oxidase 4; NADPH Oxidases; Phenylephrine; Quinazolines; Tyrphostins; Vasoconstriction; Vasodilation | 2015 |
Relationship between PDK1 and contraction in carotid arteries in Goto-Kakizaki rat, a spontaneous type 2 diabetic animal model.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Phosphoinositide-Dependent Protein Kinases; Animals; Carotid Arteries; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Indazoles; Male; Nitric Oxide; Nitric Oxide Synthase; Phenylephrine; Pyrimidines; Rats; Rats, Wistar; Serotonin; Signal Transduction; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2017 |
Effects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries.
Topics: Animals; Calcium Signaling; Carbachol; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dinoprost; Endothelium, Vascular; Hypertension, Pulmonary; Male; Membrane Potentials; Muscle, Smooth, Vascular; Nitroglycerin; Phenylephrine; Potassium; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Wistar; Serotonin; Streptozocin; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
Endothelin-mediated in vivo pressor responses following TRPV1 activation.
Topics: Adrenergic alpha-Agonists; Analysis of Variance; Animals; Azepines; Biphenyl Compounds; Blood Pressure; Capsaicin; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Femoral Artery; Indoles; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenylephrine; Receptor, Endothelin A; Receptor, Endothelin B; TRPV Cation Channels; Vasoconstriction; Vasoconstrictor Agents | 2011 |
Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression.
Topics: Adrenergic beta-Agonists; Animals; Aorta; Cattle; Caveolin 1; Caveolins; Cell Line; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Progression; Dopamine; Down-Regulation; Glycosuria; Humans; Hyperglycemia; Isoproterenol; Mice; Mice, Inbred NOD; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenylephrine; Receptor, Insulin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Serotonin; Vasodilation | 2004 |
A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
Topics: Acetates; Adrenergic alpha-Agonists; Animals; Blood Glucose; Blotting, Western; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Hypoglycemic Agents; Indoles; Lipid Peroxidation; Male; Malondialdehyde; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Phenylephrine; PPAR gamma; Receptors, Cell Surface; Receptors, Leptin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Heme oxygenase-1 gene expression increases vascular relaxation and decreases inducible nitric oxide synthase in diabetic rats.
Topics: Acetylcholine; Animals; Diabetes Mellitus; Diabetic Angiopathies; Endothelial Cells; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Nitric Oxide Synthase Type II; Phenylephrine; Rats; Rats, Sprague-Dawley; Streptozocin; Vasodilation | 2005 |
Pharmacological vascular reactivity in isolated diabetic rabbit ciliary artery.
Topics: Animals; Carbachol; Ciliary Arteries; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Isotonic Solutions; Microscopy, Electron; Phenylephrine; Potassium; Rabbits; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2006 |
Ischaemia/reperfusion-induced organ injury in low dose streptozotocin diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Intestinal Diseases; Intestine, Small; Male; Mesenteric Artery, Superior; Phenylephrine; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Streptozocin; Vasodilation | 2006 |
Participation of reactive oxygen species in diabetes-induced endothelial dysfunction.
Topics: Acetylcholine; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hyperglycemia; Male; Phenylephrine; Rats; Rats, Wistar; Reactive Oxygen Species; Streptozocin; Vascular Diseases; Vasoconstrictor Agents; Vasodilation | 2006 |
Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice.
Topics: Animals; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; ErbB Receptors; Mesenteric Arteries; Mice; Nitric Oxide Synthase Type III; Phenylephrine; Phosphorylation | 2008 |
Asymptomatic peripheral nerve dysfunction and vascular reactivity in IDDM patients with and without microalbuminuria.
Topics: Adult; Albuminuria; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Humans; Middle Aged; Neural Conduction; Norepinephrine; Peripheral Nervous System; Peripheral Nervous System Diseases; Phenylephrine; Receptors, Adrenergic, alpha-2; Regression Analysis; Vascular Resistance; Vasoconstriction | 1994 |
Effects of papaverine and prostaglandin E1 on corpus cavernosum smooth muscle of arteriogenically and diabetically impotent men.
Topics: Alprostadil; Diabetic Angiopathies; Dose-Response Relationship, Drug; Humans; Impotence, Vasculogenic; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Papaverine; Penile Erection; Phenylephrine | 1994 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothelium, Vascular; Female; Forearm; Glycated Hemoglobin; Humans; Insulin; Male; Methacholine Chloride; Nitric Oxide; Nitroprusside; Phenylephrine; Vasodilation; Verapamil | 1993 |
Reduced endothelium-mediated relaxing responses in peripheral atherosclerotic arteries from patients with and without diabetes mellitus.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothelium, Vascular; Humans; In Vitro Techniques; Male; Nitric Oxide; Phenylephrine | 1992 |
[Experiences with isolated organ studies on pathological human arteries].
Topics: Adult; Aged; Arteries; Arteriosclerosis Obliterans; Diabetic Angiopathies; Dinoprost; Female; Femoral Artery; Humans; Hypertension; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Potassium Chloride; Reference Values; Serotonin; Thromboangiitis Obliterans | 1991 |